Sarepta Therapeutics (SRPT) FCF Margin (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,997.00 |
| Dec 31, 2025 | 3,821.00 |
| Sep 30, 2025 | -4,696.00 |
| Jun 30, 2025 | 50,788.00 |
| Mar 31, 2025 | -47,851.00 |
| Dec 31, 2024 | 3,131.00 |
| Sep 30, 2024 | -1,919.00 |
| Jun 30, 2024 | 6,248.00 |
| Mar 31, 2024 | -5,050.00 |
| Dec 31, 2023 | 2,761.00 |
| Sep 30, 2023 | 58,634.00 |
| Jun 30, 2023 | -54,351.00 |
| Mar 31, 2023 | -2,703.00 |
| Dec 31, 2022 | -2,409.00 |
| Sep 30, 2022 | 71.00 |
| Jun 30, 2022 | 44,907.00 |
| Mar 31, 2022 | -45,685.00 |
| Dec 31, 2021 | 4,236.00 |
| Sep 30, 2021 | 1,059.00 |
| Jun 30, 2021 | 5,605.00 |
| Mar 31, 2021 | 76,595.00 |
| Dec 31, 2020 | 26,822.00 |
| Sep 30, 2020 | -68,409.00 |
| Jun 30, 2020 | -516,491.00 |
| Mar 31, 2020 | 485,853.00 |
| Dec 31, 2019 | -10,324.00 |
| Sep 30, 2019 | 2,347.00 |
| Jun 30, 2019 | 8,568.00 |
| Mar 31, 2019 | -1,780.00 |
| Dec 31, 2018 | 102.00 |
| Sep 30, 2018 | 132.00 |
| Jun 30, 2018 | -9,725.00 |
| Mar 31, 2018 | -1,301.00 |
| Dec 31, 2017 | 6,664.00 |
| Sep 30, 2017 | 12,373.00 |
| Jun 30, 2017 | 13,015.00 |
| Dec 31, 2014 | -10.14 Mn |
| Sep 30, 2014 | -280,809.00 |
| Jun 30, 2014 | -115,242.00 |
| Mar 31, 2014 | 15,007.00 |
| Dec 31, 2013 | -19,307.00 |
| Sep 30, 2013 | -8,761.00 |
| Jun 30, 2013 | -8,583.00 |
| Mar 31, 2013 | -23,774.00 |
| Dec 31, 2012 | 501.00 |
| Sep 30, 2012 | -5,069.00 |
| Jun 30, 2012 | 2,889.00 |